CorMedix Inc. (CRMD) NASDAQ
7.05
+0.03(+0.43%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
7.05
+0.03(+0.43%)
Currency In USD
| Market Cap | 837.76M |
| Enterprise Value | 840.84M |
| P/E Ratio | 3.41 |
| PEG Ratio | -1.92 |
| Price/Sales Ratio | 1.79 |
| Price/Book Ratio | 1.37 |
| Enterprise/Revenue | 1.8 |
| Enterprise/EBITDA | 3.39 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.52 |
| Operating Margin | 0.48 |
| Return On Assets | 0.2 |
| Return On Equity | 0.58 |
| Revenue | 311.71M |
| Revenue/Share | 3.95 |
| Gross Profit | 275.75M |
| EBITDA | 165.13M |
| Net Income | 163.06M |
| Diluted EPS | 2.04 |
| Total Cash | 149.52M |
| Total Cash/Share | 1.9 |
| Total Debt | 148.91M |
| Total Debt/Equity | 0.37 |
| Current Ratio | 2.01 |
| Book Value Per Share | 5.14 |
| 52-Week Change | 20.31 |
| 52-Week High | 17.43 |
| 52-Week Low | 5.6 |
| Moving Average 50 Days | 7.08 |
| Moving Average 200 Days | 10.37 |
| Average Volume | 2.44M |
| Shares Outstanding | 79.05M |
| % Held by Institutions | 55.26 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
| Last Split Date | March 26, 2019 |